Irsyad Khairil

Irsyad Khairil is a Pharma Analyst at the predictive health intelligence firm Airfinity, currently based in London, United Kingdom. Prior to his career in pharmaceutical market analysis, he earned a DPhil in Biochemistry from the University of Oxford, establishing a foundational background in protein engineering, molecular science, and life sciences research. Transitioning from advanced academic laboratory environments to the commercial biotechnology sector, he now leverages his technical scientific training to evaluate complex global drug development pipelines and broader biopharma market trends. Khairil specializes in generating data-driven commentary and quantitative market forecasts for industry reports, with a particular analytical emphasis on major pharmaceutical categories such as global infectious disease vaccines and metabolic drugs. His current professional focus centers on bridging rigorous biochemical research with practical health intelligence to assess the commercial trajectory of emerging biotechnology therapeutics.